This is good news.... Maybe the detail is in what the doctor said. Direct injections = 80% healing rate, which is rather high !
They have been using these cells for a while in hospitals in Australia with success too, so I wouldn't say necessarily that the IV route failed to have an effect...
What they may find, with direct injection they may get away with significantly less cells needed = lower cost of therapy = more competitive.
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis
MSB
mesoblast limited
Add to My Watchlist
4.82%
!
$2.39

Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis, page-50
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.39 |
Change
0.110(4.82%) |
Mkt cap ! $3.059B |
Open | High | Low | Value | Volume |
$2.31 | $2.43 | $2.30 | $15.10M | 6.360M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 9186 | $2.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.40 | 22000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8586 | 2.380 |
4 | 50208 | 2.370 |
4 | 39275 | 2.360 |
4 | 30375 | 2.350 |
2 | 953 | 2.340 |
Price($) | Vol. | No. |
---|---|---|
2.400 | 22000 | 3 |
2.410 | 17500 | 4 |
2.420 | 22621 | 6 |
2.430 | 48680 | 6 |
2.440 | 6900 | 2 |
Last trade - 16.11pm 23/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |